-
transmission, and predicting public health outcomes using quantitative microbial risk assessment. Lab members conduct field research in Mozambique and Indiana, as well as wet lab work in Bloomington, Indiana. We
-
modifiers. We study maternal obesity — a rapidly rising but modifiable CHD risk factor — and its convergence with non-canonical WNT/Planar Cell Polarity signaling. Using a clinically relevant high-fat-diet
-
Alzheimer’s disease pathogenesis and neurodegeneration. Ongoing projects investigate microglial signaling pathways, neuroimmune interactions, genetic risk factors, and therapeutic targets using state-of-the-art
-
discovery to identify children at risk for developing kidney disease and to guide personalized treatment strategies. By leveraging advanced technologies in genomics, proteomics, and metabolomics, our goal is